Belgian platform for pharmacists Salvus Health raises €500,000 to improve patient services
Antwerp, 4 March 2025 – Belgian startup Salvus Health, the smart service platform for pharmacists, has raised €500,000 from a group of Belgian investors. This funding will accelerate its expansion in Belgium, support the recruitment of commercial talent, and lay the groundwork for its European rollout.
Reducing pharmacists’ workload
“Pharmacists have valuable expertise and play a crucial role in society due to their proximity to patients,” explains Philip Van den Bergh, co-founder of Salvus Health. “European governments recognize their importance and support them by reimbursing services such as vaccinations and medical consultations. However, in practice, pharmacists often lack the time to take on these additional responsibilities alongside their daily tasks. Some vaccinate up to 1,500 patients in just two months. On top of that, many still rely on outdated software and struggle to fill job vacancies, which only increases their workload.”
Salvus Health helps pharmacists reclaim precious time and refocus on their advisory role. The platform automates repetitive tasks, such as scheduling appointments and sending reminders. Its integrated CRM system enables more targeted communication with patients—whether it’s displaying inhaler usage instructions on a tablet or tracking medication adherence. The software is designed to integrate seamlessly with third-party platforms, ensuring a smooth and efficient user experience.
Rapid growth
Founded in Antwerp in 2020, Salvus Health already serves over 150 pharmacies and approximately 100,000 active patients. Last year alone, 50,000 vaccination appointments were booked through the platform. The company was launched by Philip Van den Bergh, a biomedical engineer, and Salvador Severich, a serial entrepreneur from Catalonia. In 2013, Severich co-founded Signaturit, a Barcelona-based e-signature company that grew into a business with over 100 employees.
Until now, Salvus Health had been self-funded. With this new €500,000 investment from private Belgian investors and funds, the company is entering a new growth phase. “We wanted to bring in sector experts such as Georges Verpraet (pharmacy.brussels), Yves Berquin (Matrix Requirements), and Jurgen De Baerdemaeker (IQVIA),” says Salvador Severich. “At the same time, the market is evolving rapidly. That’s why we’re looking to hire commercial and marketing professionals to seize new opportunities.”
In the short term, Salvus Health aims for a 20% market share among Belgium’s 4,500 pharmacies. In the medium term, the company plans to expand into neighboring European countries. With around 160,000 pharmacies across Europe, the potential for growth is significant.
List of investors:
- Georges Verpraet (pharmacy.brussels)
- Yves Berquin (Matrix Requirements)
- Jurgen De Baerdemaeker (IQVIA)
- Angelwise
Ban Flanders helped raise the round.
Learn more about Salvus Health: https://www.salvus-health.com
